Role evidence
Usage summary
Strongest role: Inclusion Required
Inclusion-required count: 7
Treatment-assignment count: 0
Stratification count: 0
Manual Review Required
PD-L1 expression
breast cancer · Monoclonal Antibody
PD-L1 expression is flagged as manual review required because public trials show inclusion required evidence in 13 contexts. FDA CDx context exists.
Threshold snippets
Fragmentation view
Threshold count: 2
Common snippets: MSI-H | MSI-H
Threshold label: Moderate
FDA CDx context
Mapping summary
CDx label: Fda Cdx Context Exists
CDx maturity score: 5/5
Confidence: Low
Patent-density signal
Diagnostic appendix
Signal count: 1
Recent signals: 1
Density label: Low
Source links
Evidence paths
https://clinicaltrials.gov/study/NCT02536794 | https://clinicaltrials.gov/study/NCT02802098 | https://clinicaltrials.gov/study/NCT02649686 | https://clinicaltrials.gov/study/NCT04102618 | https://clinicaltrials.gov/study/NCT02752685 | https://clinicaltrials.gov/study/NCT04674722 | https://clinicaltrials.gov/study/NCT05081492 | https://clinicaltrials.gov/study/NCT05451849 | https://clinicaltrials.gov/study/NCT05402722 | https://clinicaltrials.gov/study/NCT02791334 | https://clinicaltrials.gov/study/NCT04116320 | https://clinicaltrials.gov/study/NCT04122625 | https://clinicaltrials.gov/study/NCT06305962